Literature DB >> 10656718

Standardization of broth microdilution method for Mycobacterium tuberculosis.

C Q Leite1, A L Beretta, I S Anno, M A Telles.   

Abstract

Indirect drug susceptibility tests of Mycobacterium tuberculosis was done to investigate the accuracy and feasibility of a broth microdilution method (BMM) for determining minimal inhibitory concentrations of conventional drugs against M. tuberculosis. Test drugs included isoniazid (H), rifampicin (R), ethambutol (E), streptomycin (S) and pyrazinamide (Z). Fifty isolates of M. tuberculosis from patients who had never received drug therapy, and H37Rv strain for control, were evaluated in the system. When comparing this method with the gold standard proportional method in Lowenstein-Jensen medium, sensitivity of 100% for all drugs and specifities of 91, 100, 96, 98 and 85% were observed respectively for H, R, E, S and Z. The BMM was read faster (14-20 days) than the proportional method (20-28 days). The microdilution method evaluated allows the testing of multiple drugs in multiple concentrations. It is easy to perform and does not require special equipment or expensive supplies. In contrast to radiometric method it does not use radioactive material.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656718     DOI: 10.1590/s0074-02762000000100021

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  5 in total

1.  Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.

Authors:  Zhenling Cui; Jie Wang; Junmei Lu; Xiaochen Huang; Ruijuan Zheng; Zhongyi Hu
Journal:  J Clin Microbiol       Date:  2013-02-06       Impact factor: 5.948

2.  Effect of Lagerstroemia tomentosa and Diospyros virginiana methanolic extracts on different drug-resistant strains of Mycobacterium tuberculosis.

Authors:  B Nasr Esfahani; F Hozoorbakhsh; Kh Rashed; S A Havaei; K Heidari; Sh Moghim
Journal:  Res Pharm Sci       Date:  2014 May-Jun

3.  Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.

Authors:  Paola M V Rancoita; Federica Cugnata; Ana Luíza Gibertoni Cruz; Philip W Fowler; Daniela M Cirillo; Emanuele Borroni; Sarah J Hoosdally; Timothy M Walker; Clara Grazian; Timothy J Davies; Timothy E A Peto; Derrick W Crook
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

4.  Efficacy Of Line Probe Assay In Detection Of Drug-Resistant Pulmonary Tuberculosis In Comparison With GeneXpert And Phenotypic Methods In Iran And Genetic Analysis Of Isolates By MIRU-VNTR.

Authors:  Hossein Kazemian; Jalil Kardan-Yamchi; Abbas Bahador; Shadi Khonsari; Mahshid Nasehi; Gholamreza Hamzehloo; Farzam Vaziri; Mohammad Reza Salehi; Mohammad Mehdi Feizabadi
Journal:  Infect Drug Resist       Date:  2019-11-15       Impact factor: 4.003

5.  Evaluation of the effect of Pulicaria gnaphalodes and Perovskia abrotanoides essential oil extracts against Mycobacterium tuberculosis strains.

Authors:  Fereshte Hozoorbakhsh; Bahram Nasr Esfahani; Sharareh Moghim; Gholamreza Asghari
Journal:  Adv Biomed Res       Date:  2016-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.